TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
M & U Drugge AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
144
|
168
|
195 |
| Financial expenses |
1
|
1
|
0 |
| Earnings before taxes |
-24
|
-7
|
3 |
| EBITDA |
-23
|
-6
|
4 |
| Total assets |
4
|
21
|
29 |
| Current assets |
4
|
21
|
29 |
| Current liabilities |
5
|
5
|
5 |
| Equity capital |
-15
|
8
|
16 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
-375.0%
|
38.1%
|
55.2% |
| Turnover per employee |
72
|
84
|
98 |
| Profit as a percentage of turnover |
-16.7%
|
-4.2%
|
1.5% |
| Return on assets (ROA) |
-575.0%
|
-28.6%
|
10.3% |
| Current ratio |
80.0%
|
420.0%
|
580.0% |
| Return on equity (ROE) |
160.0%
|
-87.5%
|
18.8% |
| Change turnover |
-18
|
-28
|
29 |
| Change turnover % |
-11%
|
-14%
|
18% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.